ReviewDiagnostics (Basel, Switzerland)2022

Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches.

Silvia Grassilli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.